Navigation Links
BD Announces Acquisition of Cytopeia
Date:5/13/2008

Expands Portfolio of Advanced Flow Cytometry Platforms

FRANKLIN LAKES, N.J., May 13 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has acquired all of the outstanding stock of Cytopeia, a privately held Washington corporation based in Seattle that develops and markets advanced flow cytometry cell sorting instruments.

Financial terms of this transaction were not disclosed. The acquisition is not expected to have a material impact on BD's fiscal year 2008 earnings.

"This strategic acquisition brings new technologies and capabilities that will enhance BD's ability to address growing customer needs in advanced applications, such as cell therapy research," said William A. Kozy, BD Executive Vice President. "This transaction reflects our commitment to bringing innovative tools to life scientists and will allow us to rapidly enter emerging areas of cell-based research."

Cytopeia's Influx(TM) cell sorter offers BD an open, configurable cell sorting platform that can be fully optimized for researchers' unique application-specific requirements. This high level of choice and control is particularly important for life science research on the leading edge of biomedical discovery. The Influx cell sorter is suited for a range of applications including cell therapy research, stem cell research, drug discovery and development, as well as marine biology. It complements the BD FACSAria(TM) II system -- the platform of choice in research labs around the world for a broad range of immunology cell sorting and multi-color applications.

Through the acquisition, BD gains the scientific leadership and insights of Dr. Ger van den Engh, a renowned innovator in flow cytometry.
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chindex International Announces Shelf Registration, Related Strategy and Guidance
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
4. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
5. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
6. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
7. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
8. SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
9. Aton Pharma Announces Distribution Partnership in Brazil
10. China Medicine Announces Solid First Quarter 2008 Results
11. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO ...novel oral JAK2 inhibitor, SB1518, at The American...osition in New Orleans. ,, Data will be present...scalation trial of SB1518 detailing its safety, to.../PD) profile in dose levels ranging from 100 to 60...
(Date:12/2/2009)..., QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - A...he "Company"), a global biopharmaceutical company ...nnounced that the U.S. Food and Drug Administratio... Company,s PI3K/Akt pathway inhibitor compound, pe.../refractory multiple myeloma. Keryx Biopharmaceuti...
(Date:12/2/2009)..., HOBOKEN, N.J., Dec. 2 Accordi... to 45 percent of Americans diagnosed with diabete... Diabetic retinopathy, damage to the retina cause...dness in people with diabetes and is one of the mo...80 percent of all patients who,ve had diabetes for...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportl...ort is available in its catalogue: ,, Chromiu...tlinker.com/p0164494/Chromium---Global-Market-Tren...imarily influenced by stainless steel, while growt...is also important for growth of chromium metal. En...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...ecuring venture investments, commercializing techn...ng innovative companies in Wisconsin will not read...into federal government dollars. , ,This is the p...reated by a collaboration between the Wisconsin lo...e national economic development agency GSP Consul...
... Building the Merge Healthcare of tomorrow, as c...will mean offshoring 150 jobs to a "more cost effe...8 percent of the financially troubled medical imag...tes, Canada, and Japan to regain the competitive e...ion initiative euphemistically labeled rightsizing...
...a natural biological response to the phrase securi...opaque film over the outside of the cornea wall, c... avoid this, I will do my best to stick to the ess... from comprehensive. So if your company is raising...ho is familiar with securities laws early so that ...
Other Biology Technology:New firm to help companies land federal dollars 2Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Securities compliance is part of raising capital 2Securities compliance is part of raising capital 3Securities compliance is part of raising capital 4
(Date:12/2/2009)...ur muscles can twitch, before the thought telling ...ate of sortscalled an ion channelmust open in the ... chemical signals that spur the cell to action. Ne... and Technology (NIST) has allowed scientists to o...r the first time, potentially offering insights fo...
(Date:12/2/2009)... the University of Salamanca and another from Yale...ors affects the behaviour of Acanthodactylus beer... in the Near East. According to the study, these r...ent prey if they are under pressure from predators...esult, but until now there had been very few exper...
(Date:12/1/2009)...ants have two different feeding strategies. A lar...aning that they are generalist predators feeding o...ns. Some, however, are "herbivorous". This is no...lk of their diets consist of plant-derived matter....d by plants to attract ants, called extra-floral n...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Lizards change their diet to avoid predators 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 1NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 2NIH researchers identify key factor that stimulates brain cancer cells to spread 54768 3 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 1 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 2 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 3Medicare Picks N J to Test Innovative Incentive System 54762 1Medicare Picks N J to Test Innovative Incentive System 54762 2Medicare Picks N J to Test Innovative Incentive System 54762 3Medicare Picks N J to Test Innovative Incentive System 54762 4
...ression, researchers have found that variation in ...e with age. The findings, which impact our underst...ated changes, are reported in the May 23rd issue o...t the Max Planck Institute for Evolutionary Anthro...g-standing observation concerning the physiologica...
...e autistic brain has fewer neurons in an area rela... new study published in the July 19 issue of The ...quantitative evidence linking autism to an abnorma...us—a major emotion-processing area with connection...nitive functions. , "These new findings, based...
...n and Australian researchers announced June 20, 20...he way people respond to HIV. , Through the new co...vestigators who once competed to unravel the myste...alled cohorts, they have studied. , Support for t...DS Vaccine Immunology (CHAVI), established at Duke...
Other Biology News:Gene expression becomes heterogeneous with age in humans and rats 2Autistic brain has fewer neurons for processing emotion 2CHAVI announces international search for genes affecting HIV response 2CHAVI announces international search for genes affecting HIV response 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Sf9 Insect Cells from BD Biosciences Pharmingen
Acridine orange 10-nonyl bromide from AnaSpec
HistoScan AP Universal Goat Kit from Biomeda Corporation
Biology Products: